Skip to main content
Equibles

GOLDMAN SACHS GROUP INC

Position in VNDA — Vanda Pharmaceuticals Inc.

CIK 886982 NEW YORK, NY
Back to VNDA Full portfolio

Position in VNDA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$6,341,910
+$549,721 QoQ
Shares Held
1,036,260
+23.6% QoQ
Ownership
1.71%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#16
of 172 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VNDA Over Time

Shares Held

Position Value (USD)

Derivatives in VNDA

reported options exposure · as of Jun 30, 2021
CallValue
$0
CallShares
0
PutValue
$0
PutShares
62,200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,040,380,016 across 360 Biotechnology names. VNDA ranks #180 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,481,761 $1,232,765,138
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,163,191 $725,296,113
3 ROIV
Roivant Sciences Ltd.
 18,556,458 $656,713,046
4 TECH
BIO-TECHNE Corp
 7,343,324 $518,805,838
5 RVMD
Revolution Medicines, Inc.
 2,133,101 $399,487,154
6 MRNA
Moderna, Inc.
 4,671,950 $327,176,656
7 TNGX
Tango Therapeutics, Inc.
 9,980,620 $311,994,180
8 INCY
Incyte Corp
 2,305,782 $261,383,446

All Filings in VNDA

Export CSV
43 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,341,910 1,036,260
2026-03-31 $5,792,189 838,233
2025-12-31 $3,601,575 408,342
2025-09-30 $1,695,107 339,701
2025-06-30 $1,919,769 406,731
2025-03-31 $3,184,779 693,852
2024-12-31 $3,773,642 787,817
2024-09-30 $3,566,078 760,358
2024-06-30 $2,014,484 356,546
2024-03-31 $2,077,132 505,385
2023-12-31 $1,946,318 461,213
2023-09-30 $7,225,527 1,672,576
2023-06-30 $13,862,003 2,103,491
2023-03-31 $11,209,862 1,650,937
2022-12-31 $11,020,219 1,491,234
2022-09-30 $16,844,550 1,704,914
2022-06-30 $19,976,222 1,832,681
2022-03-31 $21,268,454 1,880,500
2021-12-31 $26,692,705 1,701,256
2021-09-30 $13,983,240 815,825
2021-06-30 ALXN — 781,412
2021-06-30 ALXN — 62,200
2021-06-30 $14,162,441 658,412
2021-03-31 ALXN — 661,779
2021-03-31 ALXN — 21,000
2021-03-31 ALXN — 84,100
2021-03-31 $8,206,161 546,349
2020-12-31 ALXN — 67,100
2020-12-31 ALXN — 184,900
2020-12-31 ALXN — 770,156
2020-12-31 $10,595,267 806,337
2020-09-30 ALXN — 22,100
2020-09-30 ALXN — 94,700
2020-09-30 ALXN — 1,486,186
2020-09-30 $7,699,888 797,090
2020-06-30 ALXN — 30,100
2020-06-30 ALXN — 105,000
2020-06-30 ALXN — 1,294,363
2020-06-30 $5,941,752 519,384
2020-03-31 ALXN — 76,700
2020-03-31 ALXN — 1,328,459
2020-03-31 ALXN — 46,700
2020-03-31 $6,573,906 634,547

Report a Problem

Category
Description
Email (optional, for follow-up)